Canadian Pot Firm Tilray Goes Global With Novartis Marijuana Deal

Tilray has signed a global partnership with a division of Swiss drug giant Novartis to develop and distribute its medical marijuana in legal jurisdictions around the world. The Canadian pot firm said Tuesday it’s reached an agreement with Sandoz to boost the availability of medical cannabis products globally, building on an existing alliance with Sandoz Canada.

Source: Canadian Pot Firm Tilray Goes Global With Novartis Marijuana Deal